浙江东方(600120.SH)：东方产融拟联合浙药集团、华控投资等发起设立浙药东方开化基金

Group 1 - The core point of the article is that Zhejiang Dongfang (600120.SH) announced the establishment of the Zhejiang Medicine Dongfang Kaihua Fund, with a total fund size of 100 million yuan [1] - The fund will be managed by Dongfang Chanyun, in collaboration with Zhejiang Medicine Group and Huakong Investment, with each party contributing 1 million yuan as general partners [1] - Limited partners include designated entities from Dongfang Chanyun and Zhejiang Medicine Group, each contributing 19% of the fund, while Huakong Investment will contribute 60% [1] Group 2 - The investment constitutes a related party transaction as Zhejiang Medicine Group and Hanting Capital are wholly-owned subsidiaries of the controlling shareholder, Provincial International Trade Group [1]